Executive Summary
Marelli Europe S.P.A. appealed against the Deputy Controller's order refusing grant of a patent application, citing lack of inventive step. The appellant argued that the rejection was mechanical, merely copying prior art extracts without providing reasoned justification for why the invention lacked inventive step. The Court agreed, finding the impugned order lacked proper application of mind.
Practitioner Note
This case demonstrates the evidentiary and procedural standards applied in patent matters before Delhi High Court. Understanding the court's reasoning in Marelli Europe S.P.A. vs The Deputy Controller Of Patents And Designs is valuable context for structuring arguments or assessing risk in similar proceedings.
Related Cases
Chet ChamnitiravanichvsOrganovedics Through Its Partners Ms. Sonia and Mr. Nitin Gangadhar and Ors
In a significant ruling concerning trademark infringement, the Delhi High Court granted crucial interim relief to the plaintiff, Chet Chamnitiravanich. The court allowed the appointment of Local Commissioners to conduct an inventory and seize counterfeit 'MENA' soap products being manufactured and exported by the defendants. Furthermore, recognizing the urgency of stopping counterfeiting, the court exempted the plaintiff from mandatory advance service requirements against key defendants.
Telefonaktiebolaget Lm Ericsson (Pub)vsGionee Communication Equipment Co Ltd & Anr
The defendant filed an application seeking production of various documents, including global license agreements, declarations of essentiality to ETSI, and statements of working related to Ericsson's patents. The court observed that while some documents were relevant for FRAND determination, the burden lay on the defendant to prove comparability in trial, and thus dismissed the application.
M/S. Munjal Showa LimitedvsCommissioner Of Central Excise & St, Delhi (Gurgaon)
M/S. Munjal Showa Limited challenged demands for service tax levied on royalty payments made to M/s. Showa Corporation, Japan, concerning the transfer of technical know-how and IP rights (Patent, Utility model, Brand Service, Design, Trademark). The Tribunal ruled that since the relevant trademarks and designs were not registered in India under Indian law at the time, the services did not fall under IPR service as defined by the Finance Act, 1994. Furthermore, since the agreement was executed before the levy came into force, the demand was unsustainable.
M/S Nutrica Pusti Healthcare Pvt. Ltd.vsM/S Morepen Laboratories Ltd.
The Delhi High Court dismissed the appeal filed by Nutrica Pusti Healthcare Pvt. Ltd., upholding the Commercial Court's interim injunction against Morepen Laboratories Ltd. The court found that the marks used by the appellants were deceptively similar to those of the respondents, particularly considering the pharmaceutical context and potential for consumer confusion. This judgment reinforces the strict application of trademark principles in the highly regulated pharma sector.
Lupin Ltd.vsUnion Of India And Ors.
Lupin Ltd. challenged the NPPA's stance that it should have sought prior permission before launching an FDC drug (Empagliflozin and Metformin Hydrochloride), relying on a product patent exemption under Para 32(i) of DPCO, 2013. The court recognized the legal ambiguity regarding whether prior approval or mere intimation is required to avail this exemption.
Dealing with a patent challenge?
Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.
Disclaimer: This page contains an automated summary based on publicly available judicial records. The content is generated for informational purposes only and does not constitute legal advice. Always verify details against the original source judgment before relying on this information for any legal purpose. If you believe any information is inaccurate, please contact us.